To Curb PSE Diversion, Retailers Lead By Example With Emphasis On Tamper-Resistant Products
This article was originally published in The Tan Sheet
An HHS agency’s 2013 drug use survey shows the number of meth users rising by 155,000 after changing little the previous two years. Acura Pharmaceuticals notes the survey and Tennessee data showing that making only tamper-resistant, single-ingredient PSE products available affects the diversion rate.
You may also be interested in...
Boston University researchers recommend allowing pharmacists to dispense buprenorphine without prescriptions to expand access among the 2m consumers with opioid use disorder and help reduce the estimated 130 overdose deaths each day in the US. "It is important to attempt to address the opioid epidemic in new, effective, and safe ways. Increasing access to buprenorphine, a relatively safe medication, without a prescription could prove helpful for treating persons with OUD," say Payel Jhoom Roy and Michael Stein.
Tennessee’s meth lab seizures are up this year, but CHPA says that’s because more labs are uncovered through the state’s participation in the NPLEx stop-sale system. Rx-only bills have stalled in several states, including Indiana, where lawmakers passed a bill to cap PSE purchases at about 61 grams per year.
Officials from Mississippi, Missouri, Oregon and South Carolina and the National Narcotics Officers Associations Coalition testifying before a House subcommittee call for moving all PSE products to prescription status.